Moreover, reactivating YAP by Mst1/2 inhibitor XMU-MP-1 counteracted the inhibitory effect of ACADL on cell growth, cell cycle progression and tumorigenesis of HCC cells. This evidence concerns the gene ACADL and hepatocellular carcinoma.